Skip to content

Author

L. di Biase

We have 4 of 1,363 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Oral anticoagulation regimen after left atrial appendage occlusion in elderly atrial fibrillation patients with versus without cardiovascular comorbidities

Antithrombotic therapy is used after left atrial appendage occlusion (LAAO) to prevent device-related thrombosis (DRT) that could lead to stroke or transient ischemic attack (TIA). Ageing in atrial fibrillation (AF) as well as many age-associated comorbidities are known risk factor for stroke. Moreover, bleeding...

S. Mohanty, V. L. La Fazia, C. Gianni et al. · 0 citations
Open access Oct 2026

Association of early recurrence with extended lesion sets beyond pulmonary veins in patients with atrial fibrillation undergoing pulsed-field ablation

Prior studies have reported a significant association between early (ER) and late recurrence following catheter ablation for atrial fibrillation (AF). However, there is limited data on the factors contributing to ER post-pulsed field ablation (PFA). We aimed to assess the link between extended ablation and ER in...

S. Mohanty, V. L. La Fazia, C. Gianni et al. · 0 citations
Sep 2026

Atrial Fibrillation Cycle Length Dynamics During Pulmonary Vein Isolation and Posterior Wall Pulsed Field Ablation.

BACKGROUND The benefit of additional left atrial posterior wall ablation (LAPWA), beyond pulmonary vein isolation (PVI), in persistent atrial fibrillation (PersAF) treatment remains controversial. OBJECTIVE We investigated whether signals recorded with a pentaspline pulsed field ablation (PFA) catheter can identify P...

Lorenzo Bianchini, M. Schiavone, A. Gasperetti et al. · 0 citations
Open access Sep 2026

Effect of Pulsed Field Timing Sequence and Electrode Cooling on Ablation Safety and Efficacy Surrogates: A Preclinical Study.

BACKGROUND The variable loop circular catheter has been shown to be a safe, effective pulsed field ablation catheter for atrial fibrillation treatment. After the commercial launch of the initial waveform (Seq1), a new waveform (Seq230 mL/min) was developed that reduces electrode surface temperature and ablation deliver...

L. di Biase, Jonathan C. Hsu, Rahul Bhardwaj et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.